PURPOSEGEMPAX was an open-label, randomized phase III clinical trial designed to assess the efficacy and tolerability of gemcitabine plus paclitaxel versus gemcitabine alone as second-line treatment ...

UniCredit, Intesa Sanpaolo e Ferrari si posizionano ai vertici della classifica Top Brand Reputation realizzata da Reputation ...

SPY SPDR S&P 500 ETF 626.63 +0.30% Summary News Chart Community Historical Data Profile Options Holdings Performance Risk NYSEArca - Delayed Quote•USD ...

S&P 500 Today: Get all information on the S&P 500 Index including historical chart, news and constituents.

SGLT2 inhibitors reduced heart failure events and cardiovascular death in patients with heart failure, type 2 diabetes, chronic kidney disease, and atherosclerotic cardiovascular disease. These ...